Is constipation a side effect of GLP-1 medicines?
How common is constipation on each GLP-1?
Each prescribing label reports how many people in its trials had constipation, next to people who got a placebo (a dummy shot):
| Medicine | Who was studied | On the medicine | On placebo |
|---|---|---|---|
| Zepbound® (tirzepatide) | Adults with obesity or overweight, two trials up to 72 weeks | 11% to 17%, depending on the dose group | 5% |
| Wegovy® (semaglutide) | Adults with obesity or overweight, three trials up to 68 weeks | 24% | 11% |
| Mounjaro® (tirzepatide) | Adults with type 2 diabetes, two trials | 6% to 7% | 1% |
| Ozempic® (semaglutide) | Adults with type 2 diabetes, two trials | 3.1% to 5% | 1.5% |
From section 6.1 of each label on DailyMed: Zepbound, Wegovy (the 2.4 mg weekly trials), Mounjaro, Ozempic.
Do not read the rows as a ranking. Every label warns that side effect rates from one drug's trials "cannot be directly compared" to rates from another drug's trials. The people, doses, and lengths were different. Notice too that constipation showed up on placebo as well, especially in the weight loss trials.
Why GLP-1 medicines can cause constipation
The labels say both semaglutide and tirzepatide slow down how fast the stomach empties. Researchers think the medicines' effect on how the gut moves may also explain why constipation tends to last, though they say the evidence is not settled (Wharton et al., 2022).
Everyday changes can add to it. A GLP-1 expert consensus notes that people often drink less water because they feel full after the shot (Gorgojo-Martínez et al., 2022). And the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) lists not eating enough fiber, not drinking enough liquids, moving too little, and changing how much and what you eat among the common causes of constipation (NIDDK). Eating much less, which many people do on these medicines, can affect all of those.
How long does GLP-1 constipation last?
The best data comes from the Wegovy® trials. Pooling three of them, researchers found the typical (median) bout of constipation lasted 47 days on semaglutide, compared with 35 days on placebo. Nausea, by comparison, typically lasted 8 days, diarrhea 3, and vomiting 2. The share of people with constipation leveled off around week 10 (Wharton et al., 2022).
We did not find similar published numbers for how long constipation lasts on Zepbound® or Mounjaro®. Their labels do say most nausea, vomiting, and diarrhea happened while the dose was being raised and decreased over time.
What helps, according to health agencies
NIDDK, part of the National Institutes of Health, says you can most often treat constipation at home with a few changes (NIDDK: treatment). A 2022 expert consensus on GLP-1 stomach side effects recommends the same basics: enough fiber, more physical activity, a balanced diet, and plenty of water or other sugar-free drinks (Gorgojo-Martínez et al.).
- Add fiber, a little at a time. NIDDK says adults should get 22 to 34 grams of fiber a day depending on age and sex, and to add it slowly so your body gets used to it. Good sources it names: whole grains like oatmeal, beans and lentils, berries, apples with the skin on, pears, carrots, broccoli, green peas, and nuts (NIDDK: eating and diet). On a GLP-1 you may eat less, so a 2025 consensus review suggests about 14 grams per 1,000 calories you eat (Noronha et al., 2025). Our fiber calculator can help you find a starting number.
- Drink plenty of water and other liquids, especially as you add fiber, NIDDK says, since fluid helps fiber work. The same 2025 review suggests more than 2 to 3 liters of fluid a day during GLP-1 treatment. If you have kidney or heart problems, or a clinician has told you to limit fluids, follow their advice instead. The GLP-1 hydration calculator can help you set a daily goal.
- Move regularly. Regular physical activity may help relieve constipation, per NIDDK.
- Give it a routine. NIDDK says your doctor may suggest trying to go at the same time each day, for example 15 to 45 minutes after breakfast, and to use the bathroom as soon as you feel the need.
For meal ideas that fit a smaller appetite, see our GLP-1 diet guide and recipes.
Laxatives, stool softeners, and fiber supplements
NIDDK says a health care professional may recommend a laxative for a short time and will tell you which type is best for you. Before you take any laxative, stool softener, or fiber supplement, ask your pharmacist or clinician. They know your other medicines and your health history.
Other medicines and supplements can also make constipation worse. NIDDK's list includes iron supplements, antacids that contain aluminum and calcium, narcotic pain medicines, and some medicines for depression. Do not change or stop any medicine or supplement without talking with a health care professional, NIDDK adds.
When to call your provider
Beyond that, here is what the official sources say:
- Severe or lasting stomach problems. All four Medication Guides say: "Tell your healthcare provider if you have stomach problems that are severe or will not go away."
- Blocked bowel. Since approval, all four labels list reports of ileus (the gut slowing to a stop), intestinal obstruction, and severe constipation including fecal impaction (hard stool stuck in the bowel). These are rare and reported voluntarily, so their frequency is unknown, but they are why constipation that keeps getting worse deserves a call.
- NIDDK's red flags. See a doctor right away if you have constipation along with bleeding from your rectum, blood in your stool, constant pain in your belly, not being able to pass gas, vomiting, fever, lower back pain, or losing weight without trying (on a GLP-1 you may be losing weight on purpose, so tell your provider about the other signs). See a doctor if symptoms do not go away with self-care (NIDDK).
- Dehydration. If nausea, vomiting, or diarrhea will not stop, the Medication Guides warn that losing fluids can lead to kidney problems, and say to tell your provider right away.
Never skip, delay, or change a dose on your own because of side effects. Your prescriber can review your plan with you. Our side effects guide covers the other common ones.
Common questions
How long does constipation last on Ozempic or Wegovy?
How common is constipation on Zepbound?
Is constipation worse on Zepbound or on Wegovy?
Can I take a laxative or stool softener with my GLP-1?
Does drinking more water help constipation on a GLP-1?
When is constipation on a GLP-1 an emergency?
See the pattern, not just the bad day
FinallyMe logs side effects in a few taps and also tracks your shots, your water, and the fiber in the food you log, so you and your provider can see what lines up. Read more about the side effect tracker.
Free to download. Your logs stay on your phone.
Sources
- Eli Lilly and Company. Zepbound (tirzepatide) injection, Prescribing Information and Medication Guide. DailyMed, label version effective August 28, 2026. dailymed.nlm.nih.gov
- Novo Nordisk. Wegovy (semaglutide) injection and tablets, Prescribing Information and Medication Guide. DailyMed, label version effective June 18, 2026. dailymed.nlm.nih.gov
- Eli Lilly and Company. Mounjaro (tirzepatide) injection, Prescribing Information and Medication Guide. DailyMed, label version effective August 27, 2026. dailymed.nlm.nih.gov
- Novo Nordisk. Ozempic (semaglutide) injection, Prescribing Information and Medication Guide. DailyMed, label version effective June 1, 2026. dailymed.nlm.nih.gov
- Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, Obesity and Metabolism. 2022;24(1):94-105. doi:10.1111/dom.14551
- Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine. 2022;12(1):145. doi:10.3390/jcm12010145
- Noronha JC, Van Gaal LF, Neeland IJ, et al. Optimizing GLP-1 therapies for obesity and diabetes management. Obesity Pillars. 2025;16:100222. doi:10.1016/j.obpill.2025.100222
- National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for Constipation. NIH, last reviewed May 2018. niddk.nih.gov
- National Institute of Diabetes and Digestive and Kidney Diseases. Eating, Diet, & Nutrition for Constipation. NIH, last reviewed May 2018. niddk.nih.gov
- National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Constipation. NIH, last reviewed May 2018. niddk.nih.gov
How we pick and check sources: our editorial policy. Citations behind the app are on our sources page.
